Eyad Farah leaves McKesson Corp.
Eyad Farah, president of Health Mart and Health Mart Atlas, has left McKesson Corp. to take a role at Orsini Specialty Pharmacy.
Pharmacy
Rosacea Awareness Month to highlight importance of consistency and patience when trying new therapies
Advanced therapies designed to target rosacea’s disease processes combined with treatment plans tailored to each individual’s specific case have made it easier than ever for patients to achieve clear skin.
TDS announces investment in executive leadership
Transaction Data Systems (TDS), the leader in pharmacy software solutions, is set to take patient-centric care to the next level with the promotions of Alex Miguel to Chief Operating Officer and Grant Chapin to Senior Vice President of Mergers and Acquisitions, and the recent appointments of Tom Mul
Aurobindo receives FDA approval for pregabalin capsules
EAST WINDSOR, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application pregabalin capsules, 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg, and 300 mg.
Dr. Reddy’s launches lenalidomide capsules
Dr. Reddy’s Laboratories announced the launch, in the U.S. market, of lenalidomide capsules, a therapeutic equivalent generic version of REVLIMID (lenalidomide) Capsules approved by U. S. Food and Drug Administration. With this volume-limited launch, Dr.
Camber unveils generic Amicar
PISCATAWAY, N.J.– Camber Pharmaceuticals is pleased to announce the addition of aminocaproic acid oral solution, USP to its current portfolio. Aminocaproic acid oral solution is useful in enhancing hemostasis when fibrinolysis contributes to bleeding.
NACDS Foundation collaborative care project helps expand access to substance use disorder treatment services
ARLINGTON, Va. – On March 26, a study conducted by the University of Pittsburgh School of Pharmacy Program Evaluation and Research Unit (PERU) and funded by the National Association of Chain Drug Stores (NACDS) Foundation was published in the American Journal of Drug and Alcohol Abuse (AJDAA).
CVS Health completes acquisition of Signify Health
CVS Health announced on Wednesday that it has completed its acquisition of Signify Health.
Aetna awarded the City of New York Medicare Advantage plan contract for retirees
The City of New York Office of Labor Relations announced Thursday the award of a Medicare Advantage contract for City retirees to Aetna, a CVS Health company. The plan is being offered to approximately 250,000 retirees and their eligible dependents age 65 and over.
Uber Health embeds same-day prescription delivery into care platform
Uber Health, Uber’s healthcare arm, announced same-day prescription delivery on its HIPAA-supported, centralized platform.
Hy-Vee dietitians offering program to improve blood sugar management
Beginning in April, Hy-Vee registered dietitians will be hosting programs and events to help customers improve blood sugar management including a new virtual program starting in May for those with prediabetes, diabetes or gestational diabetes.
FDA approves O-T-C designation for Emergent BioSolutions’ NARCAN Nasal Spray
Emergent BioSolutions announced Wednesday that the U.S. Food and Drug Administration (FDA) has approved NARCAN Naloxone HCl Nasal Spray 4 mg as an over-the-counter (O-T-C) emergency treatment of opioid overdose.
Shoppers Drug Mart partners with Avicanna
Avicanna announced Tuesday that Shoppers Drug Mart has selected Avicanna as its partner to transition its Medical Cannabis by Shoppers business.
CVS Health to close acquisition of Signify Health
CVS Health announced it expects to complete its acquisition of Signify Health on or around March 29, 2023, subject to the satisfaction or waiver of the remaining customary closing conditions set forth in the merger agreement.